AstraZeneca Open Innovation Partnership

News-AZ

The Open Innovation Partnership provides an opportunity for researchers at the University of Adelaide to collaborate with AstraZeneca’s industry-leading scientists and develop new medicines.

Within this partnership, University researchers are provided access to AstraZeneca’s optimised compounds, technologies, multi-disciplinary science, high-through screening libraries, services and know-how, with the aims of publishing jointly in high profile journals, formulating drug development and commercialization plans, and seeing their ideas develop into treatments for patients.

The first stage of the application process is to present a Concept Proposal by 15 July.

Further details